UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): May 11, 2017

 

 

EXPRESS SCRIPTS HOLDING COMPANY

(Exact Name of Registrant as Specified in its Charter)

 

 

 

DELAWARE   001-35490   45-2884094

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

One Express Way, St. Louis, MO   63121
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number including area code: 314-996-0900

No change since last report

(Former Name or Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders

Express Scripts Holding Company (the “Company”) held its 2017 annual meeting of stockholders (the “Annual Meeting”) at the Company’s principal executive offices on Thursday, May 11, 2017. Of the 600,312,808 shares outstanding and entitled to vote, 530,016,456 shares were represented at the meeting, or an 88.3% quorum. The results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows:

Proposal 1. Election of Directors. All of the nominees nominated by the Board of Directors for director were elected to serve until the next annual meeting or until their respective successors are elected and qualified, by the votes set forth in the table below.

 

NOMINEE

   FOR      AGAINST      ABSTAIN      BROKER
NON-VOTES
 

Maura C. Breen

     450,857,929        14,092,885        1,827,831        63,237,811  

William J. DeLaney

     453,455,019        11,435,181        1,888,445        63,237,811  

Elder Granger, M.D., MG, USA (Retired)

     463,002,048        1,893,795        1,882,802        63,237,811  

Nicholas J. LaHowchic

     448,400,876        16,495,385        1,882,384        63,237,811  

Thomas P. Mac Mahon

     453,838,774        11,055,248        1,884,623        63,237,811  

Frank Mergenthaler

     462,935,814        1,937,390        1,905,441        63,237,811  

Woodrow A. Myers, Jr., M.D.

     452,873,549        12,026,708        1,878,388        63,237,811  

Roderick A. Palmore

     462,573,017        2,293,114        1,912,514        63,237,811  

George Paz

     458,152,797        8,078,126        547,722        63,237,811  

William L. Roper, M.D., MPH

     464,222,075        2,046,680        509,890        63,237,811  

Seymour Sternberg

     456,203,380        8,680,951        1,894,314        63,237,811  

Timothy Wentworth

     463,568,302        2,638,978        571,365        63,237,811  

Proposal 2. The appointment of Pricewaterhouse Coopers LLP as the Company’s independent registered public accountants for 2017 was ratified by the stockholders, by the votes set forth in the table below.

 

FOR

  

AGAINST

  

ABSTAIN

523,089,781

   6,205,914    720,761

Proposal 3. The stockholders approved, on a non-binding basis, executive compensation, by the votes set forth in the table below.

 

FOR

  

AGAINST

  

ABSTAIN

  

BROKER NON-VOTES

425,745,314

  

39,292,123

  

1,741,208

  

63,237,811

Proposal 4. The stockholders recommended, by non-binding vote, the holding of votes on executive compensation on an annual basis, by the votes set forth in the table below. In light of this result and other factors considered by the Board of Directors of the Company, the Board of Directors has determined that the Company will hold annual votes on executive compensation until the next advisory vote on the frequency of votes on executive compensation occurs. The next non-binding advisory vote regarding the frequency of votes on executive compensation is required to be held no later than the Company’s 2023 Annual Meeting of Stockholders, although an earlier vote may be held at the discretion of the Board of Directors.


1 YEAR

  

2 YEARS

  

3 YEARS

  

ABSTAIN

  

BROKER NON-VOTES

423,393,460

   1,275,015    41,246,152    864,018    63,237,811

Proposal 5. A stockholder proposal regarding the Chairman of the Board of Directors being an independent member of the Board of Directors was rejected by the stockholders, by the votes set forth in the table below.

 

FOR

  

AGAINST

  

ABSTAIN

  

BROKER NON-VOTES

216,893,238

   244,490,020    5,395,387    63,237,811

Proposal 6. A stockholder proposal regarding annual reporting of gender pay gaps within the Company was rejected by the stockholders, by the vote set forth in the table below.

 

FOR

  

AGAINST

  

ABSTAIN

  

BROKER NON-VOTES

32,206,092

   417,437,365    17,135,188    63,237,811


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    EXPRESS SCRIPTS HOLDING COMPANY
Date: May 12, 2017     By:  

/s/ Martin P. Akins

     

Martin P. Akins

Senior Vice President and General Counsel